Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Kenvue
KVUE
|
$344M |
| 2 |
JPMorgan Chase
JPM
|
$161M |
| 3 |
Extra Space Storage
EXR
|
$134M |
| 4 |
GE HealthCare
GEHC
|
$113M |
| 5 |
Ferguson
FERG
|
$97.1M |
Top Sells
| 1 |
PDCE
PDC Energy, Inc.
PDCE
|
$313M |
| 2 |
Super Micro Computer
SMCI
|
$305M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
$176M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
$160M |
| 5 |
Walmart
WMT
|
$112M |
Sector Composition
| 1 | Technology | 17.36% |
| 2 | Financials | 16.12% |
| 3 | Industrials | 12.99% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Annexon
ANNX
$245M
| $138K | ﹤0.01% |
58,522
+16
| +0% | +$38 |
|
3277
Q32 Bio
QTTB
$21.1M
| $138K | ﹤0.01% |
6,534
-145
| -2% | -$3.05K |
|
3278
Comstock Holding Companies
CHCI
$181M
| $135K | ﹤0.01% |
28,804
-4,890
| -15% | -$23K |
|
3279
SelectQuote
SLQT
$346M
| $134K | ﹤0.01% |
114,277
-42,739
| -27% | -$50K |
|
3280
Exagen
XGN
$217M
| $133K | ﹤0.01% |
54,399
-13,462
| -20% | -$33K |
|
|
IMMP
3281
Immutep
IMMP
$254M
| $133K | ﹤0.01% |
70,005
-11,923
| -15% | -$22.7K |
|
|
SGMA
3282
DELISTED
Sigmatron International
SGMA
| $132K | ﹤0.01% |
42,054
-2,996
| -7% | -$9.38K |
|
|
AKTS
3283
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $131K | ﹤0.01% |
173,331
-142,170
| -45% | -$107K |
|
|
SRT
3284
DELISTED
Startek Inc.
SRT
| $131K | ﹤0.01% |
40,194
-7,937
| -16% | -$25.8K |
|
3285
Immunome
IMNM
$871M
| $129K | ﹤0.01% |
15,433
| – | – |
|
3286
Orion Energy Systems
OESX
$25.7M
| $129K | ﹤0.01% |
10,215
-8,398
| -45% | -$106K |
|
3287
Immuneering
IMRX
$245M
| $128K | ﹤0.01% |
+16,684
| New | +$128K |
|
3288
Carisma Therapeutics
CARM
$18.2M
| $128K | ﹤0.01% |
30,219
-933
| -3% | -$3.95K |
|
3289
Design Therapeutics
DSGN
$349M
| $128K | ﹤0.01% |
54,115
-5,520
| -9% | -$13K |
|
3290
Werewolf Therapeutics
HOWL
$62.6M
| $124K | ﹤0.01% |
58,128
+33,515
| +136% | +$71.7K |
|
3291
Jerash Holdings
JRSH
$43.4M
| $124K | ﹤0.01% |
41,262
| – | – |
|
|
THRX
3292
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $124K | ﹤0.01% |
46,153
-32,840
| -42% | -$88.3K |
|
3293
NextCure
NXTC
$12.8M
| $123K | ﹤0.01% |
7,977
-6,601
| -45% | -$102K |
|
3294
Patriot National Bancorp
PNBK
$131M
| $121K | ﹤0.01% |
17,024
| – | – |
|
3295
Shattuck Labs
STTK
$90.1M
| $116K | ﹤0.01% |
76,345
-371
| -0.5% | -$564 |
|
3296
Astrotech Corp
ASTC
$8.5M
| $114K | ﹤0.01% |
11,276
| – | – |
|
3297
Turkcell
TKC
$4.72B
| $113K | ﹤0.01% |
23,910
-5,017
| -17% | -$23.7K |
|
3298
Sypris Solutions
SYPR
$49.3M
| $113K | ﹤0.01% |
57,143
-5,324
| -9% | -$10.5K |
|
3299
Weave Communications
WEAV
$606M
| $112K | ﹤0.01% |
13,703
| – | – |
|
3300
KORU Medical Systems
KRMD
$188M
| $111K | ﹤0.01% |
40,985
-3,700
| -8% | -$9.99K |
|